Retina/Vitreous

1-16 of 30

• 

  RestartResume

  Highlights from VBS 2026: From Care Innovations to Clinician Wellness

  RestartResume

  Highlights from VBS 2026: From Care Innovations to Clinician Wellness

  Eye on Ocular Health

  Highlights from VBS 2026: From Care Innovations to Clinician Wellness

  Akshay Thomas, M.D., M.S., FASRS

  • 

    

    Akshay Thomas, M.D., M.S., FASRS

• 

  RestartResume

  Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery

  RestartResume

  Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery

  Eye on Ocular Health

  Balancing Urgency and Outcomes in Macula-Off Retinal Detachment Surgery

  Akshay Thomas, M.D., M.S., FASRS

  • 

    

    Akshay Thomas, M.D., M.S., FASRS

• 

  RestartResume

  Retinal Vein Occlusion in Younger Patients: Key Care Considerations

  RestartResume

  Retinal Vein Occlusion in Younger Patients: Key Care Considerations

  Eye on Ocular Health

  Retinal Vein Occlusion in Younger Patients: Key Care Considerations

  Jessica Randolph, MD

  • 

    

    Jessica Randolph, MD

• 

  RestartResume

  Retinal Vein Occlusion as a Marker of Systemic Risk

  RestartResume

  Retinal Vein Occlusion as a Marker of Systemic Risk

  Eye on Ocular Health

  Retinal Vein Occlusion as a Marker of Systemic Risk

  Ashkan Abbey, MD

  • 

    

    Ashkan Abbey, MD

• 

  RestartResume

  Ischemic vs. Non-Ischemic RVO: How Do You Know?

  RestartResume

  Ischemic vs. Non-Ischemic RVO: How Do You Know?

  Eye on Ocular Health

  Ischemic vs. Non-Ischemic RVO: How Do You Know?

  Jessica Randolph, MD

  • 

    

    Jessica Randolph, MD

• 

  RestartResume

  Logistical Considerations with Anti-VEGF Treatment in Wet AMD

  RestartResume

  Logistical Considerations with Anti-VEGF Treatment in Wet AMD

  Eye on Ocular Health

  Logistical Considerations with Anti-VEGF Treatment in Wet AMD

• 

  RestartResume

  Retinal Vein Occlusion: The Case for Prompt Treatment

  RestartResume

  Retinal Vein Occlusion: The Case for Prompt Treatment

  Eye on Ocular Health

  Retinal Vein Occlusion: The Case for Prompt Treatment

  Ashkan Abbey, MD

  • 

    

    Ashkan Abbey, MD

• 

  RestartResume

  Identifying Central and Branch Retinal Vein Occlusion

  RestartResume

  Identifying Central and Branch Retinal Vein Occlusion

  Eye on Ocular Health

  Identifying Central and Branch Retinal Vein Occlusion

  Jessica Randolph, MD

  • 

    

    Jessica Randolph, MD

• 

  RestartResume

  Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion

  RestartResume

  Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion

  Eye on Ocular Health

  Distinguishing Urgent vs. Monitorable Retinal Vein Occlusion

  Ashkan Abbey, MD

  • 

    

    Ashkan Abbey, MD

• 

  RestartResume

  How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion

  RestartResume

  How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion

  Eye on Ocular Health

  How Anti-VEGF Compares with Steroids in Retinal Vein Occlusion

  Ryan Quigley

  • 

    

    Ryan Quigley

• 

  RestartResume

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  David Chin Yee, MD, FASRS

  0.25 credits

  • 

    

    David Chin Yee, MD, FASRS

  0.25 credits

• 

  RestartResume

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  David Eichenbaum, MD

  0.25 credits

  • 

    

    David Eichenbaum, MD

  0.25 credits

• 

  RestartResume

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  Deepak Sambhara, MD

  0.25 credits

  • 

    

    Deepak Sambhara, MD

  0.25 credits

• 

  RestartResume

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  RestartResume

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  CME/CE

  A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease

  Esther Lee Kim, MD

  0.25 credits

  • 

    

    Esther Lee Kim, MD

  0.25 credits

• 

  RestartResume

  Shared Care Perspectives: Retina and Optometry

  RestartResume

  Shared Care Perspectives: Retina and Optometry

  CME/CE

  Shared Care Perspectives: Retina and Optometry

  John Kitchens, MD; Sara LeMay, OD

  0.25 credits

  • 

    

    John Kitchens, MD

  • 

    

    Sara LeMay, OD

  0.25 credits

• 

  MinuteCE®

  Rethinking MacTel: Cell-based Insights for Vision Preservation

  Thomas Albini, MD; Roger A. Goldberg, MD, MBA

  1.00 credit 10 episodes

  • 

    

    Thomas Albini, MD

  • 

    

    Roger A. Goldberg, MD, MBA

  • 

    

    Dean Eliott, MD

  • 

    

    Charles C. Wykoff, MD, PhD, FACS

  1.00 credit 10 episodes

• Prev
• 1
• 2
• Next